Get started
Author

Pietro Preti

Clinical toxicity of cryopreserved circulating progenitor cells infusion.
1998 · A Zambelli, G Poggi, et al. · PubMed · 163
Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer
2004 · A. Martoni, A. Marino, et al. · European Journal of Cancer · 72
Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer
2001 · Andrea Martoni, Francesca Di Fabio, et al. · American Journal of Clinical Oncology · 45
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
1998 · A Martoni, M Guaraldi, et al. · Lung Cancer · 35
Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
1996 · P Pedrazzoli, N Gibelli, et al. · PubMed · 25
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer
1997 · P Pedrazzoli, C Perotti, et al. · British Journal of Cancer · 17
Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer.
1995 · L Pavesi, P Preti, et al. · PubMed · 15
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors.
1996 · L Torretta, C Perotti, et al. · PubMed · 13
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
1998 · P Pedrazzoli, C Perotti, et al. · PubMed · 8
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
1986 · G Robustelli della Cuna, P Zanon, et al. · PubMed · 8
Hematopoietic stem cells from different sources: biological and technical aspects.
1998 · F Bertolini, M Battaglia, et al. · PubMed · 7
Evaluation of the Effect of Medroxyprogesterone Acetate on Bone Marrow Progenitor Cells
1991 · Paolo Pedrazzoli, Giovanna Bacciocchi, et al. · Tumori Journal · 6
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer
1985 · P. Periti, G. Robustelli Delia Cuna, et al. · Investigational New Drugs · 6
Response to recombinant human erythropoietin (rHuEpo) in patients with cancer-related anaemia
1993 · P. Pedrazzoli, L. Ponchio, et al. · European Journal of Cancer · 4
Prostatic Cancer Survey of Hormonal Treatment in Europe
1990 · A. V. Bono, E. Pozzi, et al. · Journal of International Medical Research · 4
153Sm-EDTMP radionuclide treatment of bony metastatic disease: a radiation protection evaluation.
2001 · L Moro, D Fantinato, et al. · PubMed · 2
Phase II Study with Ifosfamide, Carboplatin, Etoposide (ICE Regimen) at Intermediate Dosage for Advanced Non Small Cell Lung Cancer (NSCLC)
1998 · P. Preti, G. Poggi, et al. · Journal of Chemotherapy · 2
Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors.
1985 · R Knerich, G Robustelli della Cuna, et al. · PubMed · 2
Three Conventional-Drug Combination (Ifosfamide, Carboplatin, Etoposide - ICE Regimen) in Advanced Non-Small Cell Lung Cancer (NSCLC)
2001 · A.M. Cuomo, F.S. Robustelli Della Cuna, et al. · Journal of Chemotherapy · 1
Dose Intensification of Chemotherapy in Advanced Breast Cancer: A Feasibility Phase II Study
1994 · Paolo Pedrazzoli, Claudio Zamagni, et al. · Tumori Journal · 1
1133 Comparison between CD34+ cells and CFU-GM growth in leukapheretic products of patients undergoing CPC transplant
1995 · P. Pedrazzoli, C. Perotti, et al. · European Journal of Cancer
54 HD-EPI and FEC regimen in neoadjuvant chemotherapy for primary breast cancer
1995 · G.A. Da Prada, P. Preti, et al. · European Journal of Cancer
Dose-intensification of mitomycin (MMC), methotrexate (MTX), mitoxantrone (NOV) (3 M regimen) with G-GSF rescue as first line therapy of metastatic breast cancer
1993 · P. Pedrazzoli, A. Martoni, et al. · European Journal of Cancer
Mitomycin C, Mitoxantrone and Methotrexate combination (3M) in advanced breast cancer: an effective second line therapy
1993 · L. Paveri, P. Pedrazzoli, et al. · European Journal of Cancer
Fluorouracil, epirubicin, cyclophosphamide (FEC) primary chemotherapy to avoid mastectomy in operable breast cancer
1993 · P. Pedrazzoli, P.L. Bertoli, et al. · European Journal of Cancer
Works count: 26
Citation count: 436
H-index: 8
I10-index: 8
Year
Topic
Type